Wockhardt Limited (BOM:532300)
India · Delayed Price · Currency is INR 1,363.15
+12.80 (0.95%)
At close: Jan 22, 2026
Wockhardt Market Cap
Wockhardt has a market cap or net worth of 221.07 billion as of January 23, 2026. Its market cap has decreased by -10.44% in one year.
Market Cap
221.07B
Enterprise Value
238.94B
Revenue
30.07B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,363.15
Market Cap Chart
Since February 21, 2001, Wockhardt's market cap has increased from 17.40B to 221.07B, an increase of 1,170.24%. That is a compound annual growth rate of 10.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 221.07B | -5.93% |
| Dec 31, 2025 | 235.00B | 2.08% |
| Dec 31, 2024 | 230.20B | 276.45% |
| Dec 29, 2023 | 61.15B | 90.30% |
| Dec 30, 2022 | 32.13B | -29.77% |
| Dec 31, 2021 | 45.75B | -24.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pharmaceuticals | 385.24B |
| J. B. Chemicals & Pharmaceuticals | 295.25B |
| AstraZeneca Pharma India | 206.24B |
| Jubilant Pharmova | 150.20B |
| Granules India | 134.12B |
| Caplin Point Laboratories | 132.36B |
| Rubicon Research | 109.37B |
| Sanofi India | 93.47B |